A researcher working for a pharmaceutical company is providing orientation to a new nurse researcher. The researcher determines that further education is needed when the nurse states that:
A. Clinical testing phase I involves normal volunteers
B. Preclinical testing involves volunteers
C. The manufacturer applies for FDA approval after phase III
D. Clinical testing phase III involves patients
